(0.06%) 5 472.57 points
(0.09%) 39 149 points
(0.36%) 17 781 points
(-0.19%) $80.68
(-3.66%) $2.66
(-0.76%) $2 313.20
(0.23%) $28.94
(3.59%) $1 021.80
(0.28%) $0.936
(0.70%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases...
Stats | |
---|---|
今日成交量 | 4 223 |
平均成交量 | 46 933 |
市值 | 66.86M |
EPS | $-1.150 ( Q1 | 2024-03-31 ) |
下一个收益日期 | ( $-0.960 ) 2024-08-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.700 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0460 (0.71%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-19 | Chudnovsky Yekaterina | Buy | 1 032 702 | Pre-Funded Common Stock Purchase Warrant |
2024-02-01 | Piekos Brian | Buy | 43 225 | Stock Option (right to buy) |
2024-02-01 | Connelly Robert | Buy | 225 137 | Stock Option (right to buy) |
2024-02-01 | Haqq Christopher | Buy | 28 200 | Stock Option (right to buy) |
2024-02-01 | Demuth Peter | Buy | 29 800 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 6 transactions |
Buy: 1 359 406 | Sell: 0 |
Elicio Therapeutics, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Elicio Therapeutics, Inc. 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-88.84 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-88.84 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.930 |
FY | 2019 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.505 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company\'s lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。